Price T Rowe Associates Inc Trans Medics Group, Inc. Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 258,645 shares of TMDX stock, worth $17.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
258,645
Previous 293,466
11.87%
Holding current value
$17.5 Million
Previous $46.1 Million
65.0%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding TMDX
# of Institutions
347Shares Held
30.6MCall Options Held
671KPut Options Held
858K-
Vanguard Group Inc Valley Forge, PA3.64MShares$246 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$179 Million0.01% of portfolio
-
State Street Corp Boston, MA1.36MShares$92.1 Million0.0% of portfolio
-
Fil LTD Hamilton, D01MShares$67.7 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3993KShares$67.1 Million0.07% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.15B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...